Premier Anti-Aging Co., Ltd.
Explanation Material on Business Plan and Growth Potential
Focusing on the results for the fiscal year ending July 2026 and the forecast for July 2027, the document outlines a full-scale rollout in the skin care domain centered on Skin for Longevity, expansion of the Recovery Wear business, strengthened sales channels, and group synergies for mid- to long-term growth. Although revenue is expected to be flat to slightly down year over year, brand investment and new product launches are planned to continue toward 2027.
Key Figures
- FY2026 Net sales 13,883 million yen
- FY2026 Operating income 494 million yen
- FY2026 Net income attributable to owners of the parent 364 million yen
AI要約
Section Heading
For the fiscal year ended July 2026, the plan is to balance Recovery business growth with new initiatives in the anti-aging business. Revenue is expected to be flat or slightly down versus the previous year, but will push horizontal deployment of brand development know-how such as Duo and Canadel, and full-scale expansion of the Skin for Longevity-centric skincare domain.
Section 2 Heading
For the fiscal year ending July 2027, while the sales forecast assumes level with the prior year, operating income is expected to decline significantly due to stronger advertising and promotional investments. However, by maximizing LTV, CRM initiatives, and new product launches, the company aims to build a long-term growth foundation.
Premier Anti-Aging Co., Ltd.
Company overview · Stock price · Financial data · All IR
